超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

美國ProteinOne 
ProteinOne公司位于美國馬里蘭州馬里蘭大學園區，主要研發和生產純化的活性蛋白質和蛋白質芯片平臺，應用于研究實驗室、醫學院校和制藥公司等單位。公司來自NIH的專家及一流的專業技術是質量和信心的保證。

ProteinOne公司成立于2000年10月，創始人認為在后基因組時代對純化活性蛋白和有關設備如通用蛋白芯片系統的需求越來越大。ProteinOne公司的目標是在兩年內提供300多種純化活性蛋白。

ProteinOne產品主要有：蛋白質系列、客戶定義蛋白質服務和蛋白質芯片平臺。

公司提供客戶有活性的高純度重組蛋白和天然的哺乳動物細胞內蛋白。產品類型包括普通轉錄因子、轉錄激活因子和輔助因子、mRNA前體處理因子、腫瘤抑制因子和其它腫瘤相關蛋白。

ProteinOne is a development stage biotechnology company doing business in Bethesda Maryland, USA. The primary aim of the company is to deliver purified, biologically active proteins to research labs, medical institutions and pharmaceutical companies via a Universal Protein Array (UPA) under development by the company to help companies with their drug discovery program.

The purified proteins will be sold in two different formats: through the patent pending UPA system, or Individually by request. The company’s aim is to include over 300 purified active proteins in our inventory within two years, and to successfully transfer from a prototype to an operationally complete model of the UPA.
ProteinOne's expertise in active protein production allows us to provide customers with functionally active and highly purified recombinant proteins as well as native protein fractions from mammalian cells. Our product lines include general transcription factors, transcriptional activators and coactivators, pre-mRNA processing factors, tumor suppressors and other cancer related proteins.
ProteinOne was incorporated in Delaware in October 2000. The founders believe that there exists a tremendous need for both purified, functional proteins, and delivery devices such as the Universal Protein Array system, to extend the research and commercialization of Human Genome discoveries in the post-genomic world.

ProteinOne was formed with a strong management team solidified by scientific expertise from the National Institutes of Health (NIH), and has negotiated certain licenses for the UPA to be implemented at our discretion.

In 2001, ProteinOne entered the Technology Advancement Program (TAP) at the University of Maryland, an internationally recognized business incubator providing modern laboratory facilities and centralized university affiliation.

ProteinOne continues its growth and has established itself as a leader in the medical research field with their innovative protein bioreagents. The company graduated from the TAP in 2005 and now occupy their new laboratories and administrative offices in Bethesda, Maryland.